What's New in Gastroenterology and Hepatology?
Saturday, February 11, 2012
Who Should Attend
The course is designed for gastroenterologists, GI surgeons, internists, and family practice physicians with an interest in gastroenterology and hepatology.
Purpose and Content
The purpose of this course is to provide an update in various current issues of gastroenterology, hepatology and inflammatory bowel disease. The program includes didactic lectures, case presentations, and question and answer sessions with the course faculty.
Upon completion of this course, participants should be able to link the educational objectives to Core Competencies and be able to:
- Explain new and current treatment strategies for eosinophilic esophagitis (Medical Knowledge and Patient Care)
- Review physiology, diagnostic options and management of Barretts epithelium (Medical Knowledge, Patient Care and Practice-Based Learning)
- Describe the safety of clopidogrel during colonoscopic polypectomy (Medical Knowledge and Practice-Based Learning)
- Assess clinical aspects of Clostrida difficile infection in 2012 (Medical Knowledge and Practice-Based Learning)
- Express the safety and feasability of nurse-assisted propofol administration during endoscopic procedures (Medical Knowledge, Patient Care and Practice-Based Learning)
- Review the interactions and side effects of PPI therapy
- Analyze the screening guidelines for hereditary colon cancer (Medical Knowledge)
- Describe the new and current treatments for Hepatitis C (Medical Knowledge and Practice-Based Learning)
- Examine the recent developments in Hepatology presented at AASLD(Medical Knowledge)
- Discuss current medical management of patients with chronic liver disease and liver transplantation (Medical Knowledge, Patient Care and Practice-Based Learning)
- Discuss current management of Hepatitis B (Medical Knowledge and Practice-Based Learning)
- Illustrate the new biologic agents available for IBD, and to understand some of the more difficult clinical aspects of caring for the IBD patients such as vaccination guidelines, cervical cancer screening, and drug use during pregnancy and breast feeding (Medical Knowledge, Patient Care and Practice-Based Learning)
- Report on current and new modalities for interventional endoscopy in diseases of the gallbladder, liver and pancreas (Medical Knowledge, Patient Care and Practice-Based Learning)
The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Texas Southwestern Medical Center designates this educational activity for a maximum of 5.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Conflict of Interest
It is UT Southwestern’s policy that participants in CME activities should be made aware of any affiliation or financial interest that may affect the speaker’s presentation(s). Each speaker has completed and signed a conflict of interest statement. The faculty members’ relationships will be disclosed in the course syllabus.
Discussion of Off-Label Use
Because this course is meant to educate physicians with what is currently in use and what may be available in the future, there may be “off-label” use discussed in the presentations. Speakers have been requested to inform the audience when off-label use is being discussed.